Current perspective of the HCAP problem: is it CAP or is it HAP?

Area of Science:

• Infectious Diseases
• Pulmonology
• Geriatric Medicine

Background:

• The increasing number of patients receiving healthcare outside hospitals necessitates understanding specific pneumonia risks.
• Healthcare-associated pneumonia (HCAP) is a distinct classification due to unique patient populations and risk factors.
• Current guidelines by the American Thoracic Society/Infectious Disease Society of America (ATS/IDSA) define HCAP, but clinical practice suggests additional criteria like indwelling devices.

Purpose of the Study:

• To highlight the unique characteristics of HCAP compared to community-acquired pneumonia (CAP).
• To discuss the atypical clinical presentation, risk factors, and potential etiology of HCAP.
• To emphasize the need for further research into microbial composition and multidrug-resistant infection (MRI) risk factors in HCAP.

Main Methods:

• Comparative analysis of HCAP patients versus CAP patients.
• Review of clinical presentation, comorbidities, functional status, and outcomes.
• Discussion of potential etiological agents and resistance patterns.

Main Results:

• HCAP patients are typically older, have more comorbidities, and poorer functional status than CAP patients.
• HCAP often presents with unusual symptoms like confusion and gastrointestinal issues, with milder classic respiratory signs.
• HCAP patients exhibit a worse clinical presentation and mortality rates comparable to hospital-acquired pneumonia.

Conclusions:

• HCAP represents a significant clinical challenge due to its distinct characteristics and patient population.
• The etiology of HCAP, potentially involving multidrug-resistant organisms, requires further investigation.
• Definitive therapeutic guidelines for HCAP are currently lacking, underscoring the need for continued research.